Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: April 14, 2020
Reporting Period: The filing reports on events occurring on April 14, 2020, specifically regarding upcoming investor presentations.
Key Financial Metrics
This filing does not contain specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity figures. The document serves as a disclosure notice rather than a financial statement.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing discloses the company's intent to use an investor presentation (Exhibit 99.1) for upcoming meetings with investors and analysts.
Guidance, Outlook, and Risks
Management Commentary: Executive officers plan to utilize the material in Exhibit 99.1 for investor and analyst presentations.
Regulatory Status: The information provided is furnished pursuant to Item 7.01 of Regulation FD and is not deemed "filed" for purposes of Section 18 of the Exchange Act, nor is it incorporated by reference into other filings unless expressly stated.
Emerging Growth Company: The registrant is identified as an emerging growth company and has elected not to use the extended transition period for complying with new or revised financial accounting standards.
Investor Verification Checklist
- Review Exhibit 99.1 (OrthoPediatrics Corp. Investor Presentation dated April 2020) for actual financial data and strategic outlook.
- Verify the company's status as an emerging growth company and its election regarding accounting standard transition periods.
- Confirm that the information in this 8-K is not considered "filed" under Section 18 of the Exchange Act.